Gene · 8607
NIH grants1,304
NIH grants whose papers are about the gene, through NIH's grant-paper links.
241 to 260 of 1,304
Download this page as JSON| Grant | Title | RUVBL1 papers | Newest fiscal year |
|---|---|---|---|
| ZIAAG000393 | Influence of Post-transcriptional Gene Regulation on Cell Senescence and Aging | 1 | 2025 |
| ZIAAG000726 | Function of RecQ helicases in genome stability | 1 | 2025 |
| ZIABC011627 | Molecular machines and systems contributing to cancer biology | 1 | 2025 |
| ZIADE000380 | The role of stem cells in skeletal health and disease | 1 | 2025 |
| ZIAES102605 | The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury | 1 | 2025 |
| ZIAES102745 | Role of Pluripotency Factors in Pluripotent Stem Cells, Development and Disease | 1 | 2025 |
| ZIAHL006170 | Cardiovascular Genomics and Bioinformatics projects | 1 | 2025 |
| ZIANS003155 | Mechanisms of inherited neurodegenerative diseases | 1 | 2025 |
| ZIASC010357 | Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses | 1 | 2025 |
| ZICAG000616 | Analysis of complex biological systems by high-throughput genomic technologies | 1 | 2025 |
| ZIDES102465 | Program in Clinical Research, Clinical Support Services and Clinical Training | 1 | 2025 |
| P50CA070907 | Targeting Lung Cancer Vulnerabilities | 4 | 2024 |
| R01AI114362 | Transcriptional regulatory mechanisms shaping HIV proviral fate | 2 | 2024 |
| R03CA276967 | The role of PRMT5 in preventing intra-chromosomal deletions in cancer cells | 2 | 2024 |
| DP1DA051110 | HIV-CRISPR: A novel approach to the comprehensive discovery of HIV latency factors | 1 | 2024 |
| F31CA281246 | The impact of sepsis-induced inflammation on pancreatic cancer liver metastasis | 1 | 2024 |
| K01HG010498 | Bayesian Hierarchical Methods for Localized Analysis of Genic Intolerance to Variation | 1 | 2024 |
| K08CA245235 | Defining clinically relevant transcriptional networks in gastrointestinal stromal tumor | 1 | 2024 |
| K12GM000680 | IRACDA Fellowships in Research and Science Training (FIRST) | 1 | 2024 |
| K23AR073927 | Skeletal Myopathy in Systemic Sclerosis: Devising a Classification Schema Predictive of Outcomes | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8607/grants?page=13